Rta Laboratuvarlari Biyolojik Stock EBITDA
| RTALB Stock | TRY 12.91 0.01 0.08% |
RTA Laboratuvarlari Biyolojik fundamentals help investors to digest information that contributes to RTA Laboratuvarlari's financial success or failures. It also enables traders to predict the movement of RTA Stock. The fundamental analysis module provides a way to measure RTA Laboratuvarlari's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RTA Laboratuvarlari stock.
RTA |
RTA Laboratuvarlari Biyolojik Company EBITDA Analysis
RTA Laboratuvarlari's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current RTA Laboratuvarlari EBITDA | 171.39 M |
Most of RTA Laboratuvarlari's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RTA Laboratuvarlari Biyolojik is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, RTA Laboratuvarlari Biyolojik reported earnings before interest,tax, depreciation and amortization of 171.39 M. This is 80.47% lower than that of the Biotechnology sector and 71.12% higher than that of the Health Care industry. The ebitda for all Turkey stocks is 95.6% higher than that of the company.
RTA EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RTA Laboratuvarlari's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RTA Laboratuvarlari could also be used in its relative valuation, which is a method of valuing RTA Laboratuvarlari by comparing valuation metrics of similar companies.RTA Laboratuvarlari is currently under evaluation in ebitda category among related companies.
RTA Fundamentals
| Return On Equity | 0.52 | |||
| Return On Asset | 0.0138 | |||
| Profit Margin | 1.10 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 100 M | |||
| Shares Owned By Insiders | 29.39 % | |||
| Shares Owned By Institutions | 0.10 % | |||
| Price To Earning | 5.85 X | |||
| Price To Book | 2.44 X | |||
| Price To Sales | 6.09 X | |||
| Revenue | 384.34 M | |||
| Gross Profit | 141.18 M | |||
| EBITDA | 171.39 M | |||
| Net Income | 114.47 M | |||
| Cash And Equivalents | 71.88 M | |||
| Cash Per Share | 0.72 X | |||
| Total Debt | 307.94 K | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 2.44 X | |||
| Book Value Per Share | 5.22 X | |||
| Cash Flow From Operations | 68.78 M | |||
| Earnings Per Share | 2.08 X | |||
| Number Of Employees | 87 | |||
| Beta | 0.33 | |||
| Market Capitalization | 830 M | |||
| Total Asset | 552.4 M | |||
| Retained Earnings | 26 M | |||
| Working Capital | 28 M | |||
| Current Asset | 39 M | |||
| Current Liabilities | 11 M | |||
| Net Asset | 552.4 M |
About RTA Laboratuvarlari Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RTA Laboratuvarlari Biyolojik's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RTA Laboratuvarlari using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RTA Laboratuvarlari Biyolojik based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RTA Laboratuvarlari Biyolojik. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the RTA Laboratuvarlari information on this page should be used as a complementary analysis to other RTA Laboratuvarlari's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for RTA Stock analysis
When running RTA Laboratuvarlari's price analysis, check to measure RTA Laboratuvarlari's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RTA Laboratuvarlari is operating at the current time. Most of RTA Laboratuvarlari's value examination focuses on studying past and present price action to predict the probability of RTA Laboratuvarlari's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RTA Laboratuvarlari's price. Additionally, you may evaluate how the addition of RTA Laboratuvarlari to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |